Factor VIII inhibitors in haemophiliacs, Lancet, vol.340, p.253, 1992. ,
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A, J Thromb Haemost, vol.7, pp.2006-2021, 2009. ,
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort, Blood, vol.121, pp.1446-54, 2013. ,
Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIII, Blood, vol.115, pp.2682-2687, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455593
T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site, J Thromb Haemost, vol.9, pp.689-99, 2011. ,
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII, J Clin Invest, vol.125, pp.3766-81, 2015. ,
Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance? Haematologica, vol.104, pp.236-280, 2019. ,
Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A, Blood, vol.112, pp.240-249, 2008. ,
HLA-DR-presented peptide repertoires derived from human monocytederived dendritic cells pulsed with blood coagulation factor VIII, Mol Cell Proteomics, vol.10, 2011. ,
A role for exposed mannosylations in presentation of human therapeutic selfproteins to CD4+ T lymphocytes, Proc Natl Acad Sci, vol.104, pp.8965-70, 2007. ,
Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain, J Allergy Clin Immunol, vol.129, pp.1-5, 2012. ,
Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice, Blood, vol.119, pp.5294-300, 2012. ,
The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells, Haematologica, vol.102, pp.271-81, 2016. ,
Mannose-sensitive receptors mediate the uptake of factor VIII therapeutics by human dendritic cells, J Allergy Clin Immunol, vol.129, pp.1172-1175, 2012. ,
Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversedphase high-performance liquid chromatography-electrospray ionization mass spectrometry, Anal Chem, vol.69, pp.3986-94, 1997. ,
Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII, Thromb Res, vol.131, pp.78-88, 2013. ,
In-depth comparison of N-glycosylation of human plasma-derived factor VIII and different recombinant products: from structure to clinical implications, J Thromb Haemost, vol.16, pp.1592-603, 2018. ,
Predictive immunogenicity of Refacto AF, Haemophilia, vol.20, pp.486-92, 2014. ,
Mannose receptor-mediated regulation of serum glycoprotein homeostasis, Science, vol.295, pp.1898-901, 2002. ,
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A, Nat Genet, vol.10, pp.119-140, 1995. ,
A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice, Eur J Immunol, vol.34, pp.3060-3069, 2004. ,
A new recombinant procoagulant protein derived from the cDNA encoding human factor VIII, Protein Eng, vol.2, pp.301-307, 1988. ,
Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain, Biochem J, pp.23-31, 1991. ,
Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII, Blood, vol.92, pp.3701-3710, 1998. ,
Slowed release of thrombincleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition, J Biol Chem, vol.271, pp.27424-27455, 1996. ,
Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants, Arterioscler Thromb Vasc Biol, vol.28, pp.419-443, 2008. ,
Willebrand factor clearance does not involve proteolysis by ADAMTS-13, J Thromb Haemost, vol.8, pp.2338-2378, 2010. ,
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow, J Immunol Methods, vol.223, pp.77-92, 1999. ,
CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A, Blood, vol.101, pp.1351-1359, 2003. ,
Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor, Blood, vol.92, pp.496-506, 1998. ,
Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A, Haemophilia, vol.18, pp.248-54, 2012. ,
Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII, Biochem J, vol.475, pp.873-86, 2018. ,
EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII, Blood, vol.115, pp.1081-1088, 2010. ,
LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII, J Thromb Haemost, vol.1, pp.2360-2367, 2003. ,
The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner, J Thromb Haemost, vol.17, pp.681-94, 2019. ,
Galectin-1 and Galectin-3 constitute novel-binding partners for Factor VIII, Arterioscler Thromb Vasc Biol, vol.36, pp.855-63, 2016. ,
Differential site accessibility mechanistically explains subcellular-specific N-glycosylation determinants, Front Immunol, vol.5, p.404, 2014. ,
Antigenic targeting of the human mannose receptor induces tumor immunity, J Immunol, vol.178, pp.6259-67, 2007. ,
Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses, PLoS One, vol.7, p.46959, 2012. ,
Self-and nonself-recognition by C-type lectins on dendritic cells, Annu Rev Immunol, vol.22, pp.33-54, 2004. ,
The mannose receptor, J Leukoc Biol, vol.92, pp.1177-86, 2012. ,
Transcriptional profiling of human dendritic cell populations and models-unique profiles of in vitro dendritic cells and implications on functionality and applicability, PLoS One, vol.8, p.52875, 2013. ,
VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors, Blood, vol.109, pp.610-612, 2007. ,
Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells, J Exp Med, vol.189, pp.1961-72, 1999. ,
The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation, J Immunol, vol.176, pp.6770-6776, 2006. ,
Expression of mannose receptor and ligands for its cysteine-rich domain in venous sinuses of human spleen, Lab Invest, vol.85, pp.1238-1287, 2005. ,
DEC-205/CD205+ dendritic cells are abundant in the white pulp of the human spleen, including the border region between the red and white pulp, Int J Mol Sci, vol.123, pp.10113-10144, 2008. ,
Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A, J Thromb Haemost, vol.7, pp.1816-1839, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455596
, Therapeutic Strategies Against FVIII Immune Response in Hemophilia A?: By Modifying FVIII Structure, by Inhibiting B Cells Signalisation, 2017.
URL : https://hal.archives-ouvertes.fr/tel-01537891